MCA
PFE icon

Mercer Capital Advisers’s Pfizer PFE Stock Holding History

Mercer Capital Advisers’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$963K Sell
22,398
-703
-3% -$31.1K 0.52% 36
2021
Q2 		$905K Sell
23,101
-300
-1% -$11.7K 0.45% 40
2021
Q1 		$848K Sell
23,401
-50
-0.2% -$1.77K 0.45% 42
2020
Q4 		$863K Sell
23,451
-1,266
-5% -$46.4K 0.48% 37
2020
Q3 		$861K Buy
24,717
+575
+2% +$20.2K 0.53% 32
2020
Q2 		$749K Buy
24,142
+1,054
+5% +$35.8K 0.48% 37
2020
Q1 		$715K Sell
23,088
-1,861
-7% -$63.4K 0.53% 35
2019
Q4 		$927K Sell
24,949
-36
-0.1% -$1.28K 0.56% 39
2019
Q3 		$852K Hold
24,985
– – 0.54% 38
2019
Q2 		$1.03M Sell
24,985
-738
-3% -$29.3K 0.66% 33
2019
Q1 		$1.04M Sell
25,723
-1,204
-4% -$48.2K 0.7% 33
2018
Q4 		$1.11M Hold
26,927
– – 0.83% 30
2018
Q3 		$1.13M Buy
26,927
+686
+3% +$26.4K 0.75% 30
2018
Q2 		$903K Hold
26,241
– – 0.65% 35
2018
Q1 		$884K Buy
26,241
+342
+1% +$11.8K 0.65% 34
2017
Q4 		$890K Hold
25,899
– – 0.64% 34
2017
Q3 		$877K Sell
25,899
-53
-0.2% -$1.7K 0.65% 35
2017
Q2 		$827K Hold
25,952
– – 0.62% 34
2017
Q1 		$842K Sell
25,952
-52
-0.2% -$1.64K 0.65% 32
2016
Q4 		$801K Sell
26,004
-316
-1% -$9.65K 0.64% 32
2016
Q3 		$846K Hold
26,320
– – 0.68% 30
2016
Q2 		$879K Sell
26,320
-527
-2% -$16.8K 0.72% 26
2016
Q1 		$755K Sell
26,847
-422
-2% -$12.1K 0.65% 31
2015
Q4 		$835K Hold
27,269
– – 0.74% 26
2015
Q3 		$813K Sell
27,269
-211
-0.8% -$6.76K 0.75% 24
2015
Q2 		$874K Buy
27,480
+1,581
+6% +$51.5K 0.78% 25
2015
Q1 		$855K Sell
25,899
-843
-3% -$26.8K 0.77% 23
2014
Q4 		$790K Buy
+26,742
New +$767K 0.7% 26

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Mercer Capital Advisers's PFE Position: Q3 2021 in Review

Mercer Capital Advisers reduced its Pfizer (PFE) stake by 3% in Q3 2021, selling an estimated $31.1K and leaving 22,398 shares worth $963K. The position accounts for 0.52% of the portfolio, ranked #36.

Mercer Capital Advisers first reported a position in PFE in Q4 2014 and has held it in 28 quarters since. The position peaked at $1.13M in Q3 2018. 2,803 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

  • Mercer Capital Advisers held 22,398 shares of Pfizer worth $963K as of Q3 2021.
  • Mercer Capital Advisers sold 703 Pfizer shares in Q3 2021, an estimated $31.1K.
  • Pfizer made up 0.52% of Mercer Capital Advisers's portfolio in Q3 2021, its #36 holding.
  • Mercer Capital Advisers first reported a position in Pfizer in Q4 2014 and has held it in 28 quarters since.
  • Mercer Capital Advisers's Pfizer position peaked at $1.13M in Q3 2018.
  • 2,803 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on Mercer Capital Advisers's 13F filing for Q3 2021, filed 27 Oct 2021.